These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32242053)
1. Author Correction: PHF14: an innate inhibitor against the progression of renal fibrosis following folic acid-induced kidney injury. Yang B; Chen S; Wu M; Zhang L; Ruan M; Chen X; Chen Z; Mei C; Mao Z Sci Rep; 2020 Apr; 10(1):6036. PubMed ID: 32242053 [TBL] [Abstract][Full Text] [Related]
2. PHF14: an innate inhibitor against the progression of renal fibrosis following folic acid-induced kidney injury. Yang B; Chen S; Wu M; Zhang L; Ruan M; Chen X; Chen Z; Mei C; Mao Z Sci Rep; 2017 Jan; 7():39888. PubMed ID: 28045076 [TBL] [Abstract][Full Text] [Related]
3. Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis. McWilliam SJ; Rosala-Hallas A; Jones AP; Shaw V; Greenhalf W; Jaki T; Smyth AR; Smyth RL; Pirmohamed M Sci Rep; 2020 Mar; 10(1):4730. PubMed ID: 32152372 [TBL] [Abstract][Full Text] [Related]
4. Author Correction: (-)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats. Luo D; Xu J; Chen X; Zhu X; Liu S; Li J; Xu X; Ma X; Zhao J; Ji X Sci Rep; 2020 Jun; 10(1):10586. PubMed ID: 32601353 [TBL] [Abstract][Full Text] [Related]
5. Author Correction: RNA-seq of serial kidney biopsies obtained during progression of chronic kidney disease from dogs with X-linked hereditary nephropathy. Chu CP; Hokamp JA; Cianciolo RE; Dabney AR; Brinkmeyer-Langford C; Lees GE; Nabity MB Sci Rep; 2020 Feb; 10(1):2381. PubMed ID: 32024902 [TBL] [Abstract][Full Text] [Related]
6. Author Correction: Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population. Chang TJ; Zheng CM; Wu MY; Chen TT; Wu YC; Wu YL; Lin HT; Zheng JQ; Chu NF; Lin YM; Su SL; Lu KC; Chen JS; Sung FC; Lee CT; Yang Y; Hwang SJ; Wang MC; Hsu YH; Chiou HY; Kao S; Lin YF Sci Rep; 2020 Feb; 10(1):2822. PubMed ID: 32054951 [TBL] [Abstract][Full Text] [Related]
7. Author Correction: Altered proximal tubular cell glucose metabolism during acute kidney injury is associated with mortality. Legouis D; Ricksten SE; Faivre A; Verissimo T; Gariani K; Verney C; Galichon P; Berchtold L; Feraille E; Fernandez M; Placier S; Koppitch K; Hertig A; Martin PY; Naesens M; Pugin J; McMahon AP; Cippà PE; de Seigneux S Nat Metab; 2020 Sep; 2(9):989. PubMed ID: 32873966 [TBL] [Abstract][Full Text] [Related]
9. Correction: 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression. Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S Cell Death Dis; 2019 Jul; 10(8):543. PubMed ID: 31320606 [TBL] [Abstract][Full Text] [Related]
10. Author Correction: Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity. Solis AG; Bielecki P; Steach HR; Sharma L; Harman CCD; Yun S; de Zoete MR; Warnock JN; To SDF; York AG; Mack M; Schwartz MA; Cruz CSD; Palm NW; Jackson R; Flavell RA Nature; 2019 Nov; 575(7784):E7. PubMed ID: 31712625 [TBL] [Abstract][Full Text] [Related]
11. Author Correction: Targeting cardiac fibrosis with engineered T cells. Aghajanian H; Kimura T; Rurik JG; Hancock AS; Leibowitz MS; Li L; Scholler J; Monslow J; Lo A; Han W; Wang T; Bedi K; Morley MP; Saldana RAL; Bolar NA; McDaid K; Assenmacher CA; Smith CL; Wirth D; June CH; Margulies KB; Jain R; Puré E; Albelda SM; Epstein JA Nature; 2019 Dec; 576(7785):E2. PubMed ID: 31723271 [TBL] [Abstract][Full Text] [Related]
12. Author Correction: Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population. Zheng CM; Wang JY; Chen TT; Wu YC; Wu YL; Lin HT; Chiu SP; Chang TJ; Zheng JQ; Chu NF; Lin YM; Su SL; Lu KC; Chen JS; Sung FC; Lee CT; Yang Y; Hwang SJ; Wang MC; Hsu YH; Chiou HY; Kao S; Wu MY; Lin YF Sci Rep; 2020 Apr; 10(1):6631. PubMed ID: 32296120 [TBL] [Abstract][Full Text] [Related]
16. Author Correction: Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing. Maule G; Casini A; Montagna C; Ramalho AS; De Boeck K; Debyser Z; Carlon MS; Petris G; Cereseto A Nat Commun; 2020 Oct; 11(1):5457. PubMed ID: 33093446 [TBL] [Abstract][Full Text] [Related]
17. Author Correction: Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis. Kato M; Sasaki S; Nakamura T; Kurokawa K; Yamada T; Ochi Y; Ihara H; Takahashi F; Takahashi K Sci Rep; 2020 Jul; 10(1):12080. PubMed ID: 32669649 [TBL] [Abstract][Full Text] [Related]
18. Author Correction: Cellular census of human fibrosis defines functionally distinct stromal cell types and states. Layton TB; Williams L; McCann F; Zhang M; Fritzsche M; Colin-York H; Cabrita M; Ng MTH; Feldmann M; Sansom SN; Furniss D; Xie W; Nanchahal J Nat Commun; 2020 Jun; 11(1):3275. PubMed ID: 32581254 [TBL] [Abstract][Full Text] [Related]
19. Author Correction: Role of intestinal trefoil factor in protecting intestinal epithelial cells from burn-induced injury. Hu J; Shi Y; Wang C; Wan H; Wu D; Wang H; Peng X Sci Rep; 2020 Jul; 10(1):12741. PubMed ID: 32704055 [TBL] [Abstract][Full Text] [Related]
20. Author Correction: Inducible degradation of lncRNA Sros1 promotes IFN-γ-mediated activation of innate immune responses by stabilizing Stat1 mRNA. Xu H; Jiang Y; Xu X; Su X; Liu Y; Ma Y; Zhao Y; Shen Z; Huang B; Cao X Nat Immunol; 2020 Apr; 21(4):477-478. PubMed ID: 32099101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]